Search research articles
Contact Us
Filters
Showing results (51-60 of 117) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2011
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer
Adam D Steg, Ashwini A Katre, Blake Goodman, et al.
Cancer Research
|
January 20, 2007
Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination
Tae Heung Kang, Jin Hyup Lee, Chung Kil Song, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
March 9, 2019
Repositioning of the antipsychotic drug TFP for sepsis treatment
Jung Hwa Park, Hyun Jin Park, Sung Eun Lee, et al.
Molecular Medicine (Cambridge, Mass.)
|
July 23, 2016
Annexin A5 increases survival in murine sepsis model by inhibiting HMGB1-mediated pro-inflammation and coagulation
Jung Hwa Park, Jong-Hwa Jang, Eun Jung Choi, et al.
Journal for Immunotherapy of Cancer
|
March 2, 2019
A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine
Hyun Jin Park, Gun-Young Jang, Young Seob Kim, et al.
Endocrine-Related Cancer
|
September 24, 2010
Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis
Shu Feng, Irina U Agoulnik, Anne Truong, et al.
Hepatology (Baltimore, Md.)
|
February 8, 2013
Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520
Yun-Yong Park, Sang-Bae Kim, Hee Dong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2012
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer
Angela J Ziebarth, Somaira Nowsheen, Adam D Steg, et al.
Biochemical and Biophysical Research Communications
|
April 2, 2017
Neoagarooligosaccharides prevent septic shock by modulating A20-and cyclooxygenase-2-mediated interleukin-10 secretion in a septic-shock mouse model
Da Rae Kang, Gun Young Yoon, Joon Cho, et al.
Cancer Biology & Therapy
|
October 24, 2019
Clinical and biological significance of <i>EZH2</i> expression in endometrial cancer
Ju-Won Roh, Jung Eun Choi, Hee Dong Han, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 117) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2011
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer
Adam D Steg, Ashwini A Katre, Blake Goodman, et al.
Cancer Research
|
January 20, 2007
Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination
Tae Heung Kang, Jin Hyup Lee, Chung Kil Song, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
March 9, 2019
Repositioning of the antipsychotic drug TFP for sepsis treatment
Jung Hwa Park, Hyun Jin Park, Sung Eun Lee, et al.
Molecular Medicine (Cambridge, Mass.)
|
July 23, 2016
Annexin A5 increases survival in murine sepsis model by inhibiting HMGB1-mediated pro-inflammation and coagulation
Jung Hwa Park, Jong-Hwa Jang, Eun Jung Choi, et al.
Journal for Immunotherapy of Cancer
|
March 2, 2019
A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine
Hyun Jin Park, Gun-Young Jang, Young Seob Kim, et al.
Endocrine-Related Cancer
|
September 24, 2010
Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis
Shu Feng, Irina U Agoulnik, Anne Truong, et al.
Hepatology (Baltimore, Md.)
|
February 8, 2013
Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520
Yun-Yong Park, Sang-Bae Kim, Hee Dong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2012
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer
Angela J Ziebarth, Somaira Nowsheen, Adam D Steg, et al.
Biochemical and Biophysical Research Communications
|
April 2, 2017
Neoagarooligosaccharides prevent septic shock by modulating A20-and cyclooxygenase-2-mediated interleukin-10 secretion in a septic-shock mouse model
Da Rae Kang, Gun Young Yoon, Joon Cho, et al.
Cancer Biology & Therapy
|
October 24, 2019
Clinical and biological significance of <i>EZH2</i> expression in endometrial cancer
Ju-Won Roh, Jung Eun Choi, Hee Dong Han, et al.
Page
of 12